With the recent exciting advances in cannabis research, and its improved reputation in both the medicinal world and for recreational use, what should we expect the next 12 months to bring? Will this be the year of the edibles, should we focus on genetics, or will terpenes steal the show?
Pesticide use can be a big problem for the cannabis industry and rigorous testing is helping to ensure clean and safe products reach patients and the recreational market. We discuss the current challenges faced and the future of pesticide testing.
Five different plant pathogens were identified in the crown tissues of wilted plants highlighting the need for better environmental controls and cultivation practices for outdoor grows.
Apart from the obvious adverse effects these fungal infections have on plant crops, some can cause adverse health effects in humans.
Microbes can be introduced to cannabis products during the growing and processing phases. This is a challenging area for microbiologists, and requires them to implement a variety of techniques in order to create medical-grade cannabis.
Unveiling the genetic map and key genes within the cannabis genome will enable the development of bespoke cannabis strains with controlled cannabinoid content.
Demand for cannabis is outweighing supply in Canada, meaning consumer disappointment and a possible resurgence in black market product.